The British pharma giant said Emma Walmsley's current pay could put off candidates for her eventual successor.

British drugmaker GSK will no longer set diversity targets, it said on Thursday, as it became the latest company to scale ...

For GSK CEO Emma Walmsley, there was good news and bad news in the company’s annual report. | For GSK CEO Emma Walmsley, ...

One of the lowest paid CEOs in pharma—and the only woman leading a top-tier giant—is set to receive up to $27.2 million in ...

GSK boss Walmsley (left) received £10.6m in salary and bonuses in 2024 while Blanc (right), head of insurance group Aviva, ...

There is no escaping from the fact that the British company has proved perennially disappointing for investors. Around £10bn ...

UK drugmaker says Emma Walmsley is underpaid compared with global competitors as it abandons diversity targets ...

LON:GSK opened at GBX 1,429 ($18.05) on Friday. The company has a debt-to-equity ratio of 114.64, a quick ratio of 0.73 and a current ratio of 0.81. The firm has a market cap of £57.99 billion ...

While both broadly agreed with the company’s plans to spin off its consumer-health unit, they questioned whether Chief ...

Drugmakers and analysts fear retaliation from Brussels will only exacerbate Europe’s drug supply issues. After raising ...

GSK's revenue and EPS exceeded my expectations and those of analysts. Check out the reasons why I am upgrading GSK stock's ...